pp1420
Biologicalexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2010 (NCT01052493)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pp1420
- pp 1420
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02221765 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2014 | University of London, Wellcome Trust |
| NCT01052493 | Phase 1 | Apr 1, 2010 | University of London, Wellcome Trust |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of London | Academic/Hospital | 2 | 2 | 2 | 2010 |
| Wellcome Trust | Academic/Hospital | 2 | 0 | 2 | 2010 |
2 organizations
Page 1 / 1